Pernille W.
- Country
- Denmark
- Department
- Department of Paediatric and Adolescent Medicine
Research Overview
- Randomized Phase II/III Study of Cabozantinib Maintenance Versus Best Supportive Care in Osteosarcoma Patients After First‑Line Chemotherapy (FOSTER‑CabOS)
- Evaluation of Irinotecan, Ifosfamide, Vincristine, and Dactinomycin in Frontline and Relapsed Rhabdomyosarcoma in Pediatric and Adult Populations
Data & Insights
Has run more than one trial at 47 of 185 partner sites.
Specializations
Pediatric and Adult Oncology
This investigator specializes in the treatment of rhabdomyosarcoma, conducting comprehensive research spanning both pediatric and adult patient populations. Their work encompasses frontline treatment approaches and management strategies for relapsed cases.
- Primary Site Management
- Metastatic Disease Treatment
- Risk-Adapted Therapy
Their expertise extends to treating both localized and advanced stages of disease, with particular attention to risk stratification approaches.
Therapeutic Innovation
The investigator focuses on developing novel therapeutic combinations, including systemic therapy regimens and innovative drug combinations. Their research explores the integration of traditional chemotherapy agents with newer therapeutic approaches.
- Combination Therapy Development
- Dose Optimization Studies
- Maintenance Treatment Strategies
Their work includes evaluation of treatment intensification strategies and novel maintenance approaches for high-risk patients.
Radiation Oncology
The investigator's expertise includes comprehensive research in radiotherapy optimization, examining timing and dosing strategies. Their work explores various approaches to radiation delivery and its integration with other treatment modalities.
- Pre-operative Radiation
- Post-operative Protocols
- Dose Escalation Studies
Their research includes investigation of radiation approaches for both local and metastatic disease sites.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.